What does it mean when pathology report says positive margins
Ask Navis about your situation
This answer is general. Get one about your specific case — no signup, answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Understanding Positive Margins on a Pathology Report
When a pathology report says you have positive margins, it means that cancer cells were found at the edge of the tissue that was removed during surgery. Think of it this way: the surgeon removed a piece of tissue, and when the pathologist examined it under the microscope, they found tumor cells right at the outer boundary of that removed tissue.
Why This Matters
Positive margins suggest that:
- Cancer cells may still be present in the body beyond what was surgically removed
- There's a higher risk that some cancer was left behind in the area where the surgery took place
- Additional treatment or a second surgery may be needed to remove any remaining cancer
This is different from negative margins (also called "clear margins"), which means the surgeon successfully removed the tumor with a border of healthy tissue around it—like a safety zone.
What Typically Happens Next
According to NCCN (National Comprehensive Cancer Network) Guidelines, when positive margins are found, oncologists generally consider:
- Re-excision surgery - Going back in to remove more tissue from that area
- Radiation therapy - To target any remaining cancer cells in that region
- Systemic treatments - Chemotherapy or other drugs to address cancer throughout the body
- Combination approaches - Using multiple treatments together
The specific approach depends on your cancer type, location, and other factors in your case.
Questions to Ask Your Oncologist
Since positive margins require a treatment plan tailored to YOUR situation, ask your doctor:
- What does "positive margin" mean for my specific cancer type and location?
- Do you recommend re-excision surgery, radiation, or another approach?
- How will this change my overall treatment plan?
- What's the goal of the next treatment—to eliminate remaining cancer or reduce recurrence risk?
- What are the potential side effects of the recommended approach?
Getting More Information
The American Cancer Society and NCI (National Cancer Institute) both have detailed resources about surgical margins and what they mean for different cancer types. Your pathology report should also specify which margins were positive (this varies by cancer location), which is important context for your doctor's recommendations.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Ask Navis about your case
That answer is general. Ask about your specific situation — no signup, answered right here.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Related Services
Services that may help with diagnosis for cancer patients
Have your records handy? Upload them for a deeper, personalized analysis →
Related Questions
Just finished the perspective therapeutics VMT-a-NET phase 1b dosing trial These are the results of my latest PET...
TL;DR: Your latest PET scan shows your cancer is stable—the tumors in your liver are about the same size as before, no new tumors appeared, and the tr
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
We are in the UK royal marsden. It is kind of hopeless or how to say? Is there any immunetherapy worth to pursue or...
TL;DR: Diffuse midline gliomas DMGs with H3K27M are very challenging, but immunotherapy and targeted approaches are actively being researched—the Roya
It is my daughter she completed 6 weeks of radio and tmz now she is on 3rd cycle of tmz 200mg. We are doing low meth...
TL;DR: Your daughter's treatment plan radiation + TMZ chemotherapy is standard for diffuse midline glioma, and her biomarkers MGMT methylated, EGFR A2